| Authors: |
Bernshtein B; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Curato C; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Ioannou M; Francis Crick Institute, London NW1 1AT, UK., Thaiss CA; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Gross-Vered M; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Kolesnikov M; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Wang Q; Francis Crick Institute, London NW1 1AT, UK., David E; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Chappell-Maor L; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Harmelin A; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot 76100, Israel., Elinav E; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel., Thakker P; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River, Tarrytown, NY 10591, USA., Papayannopoulos V; Francis Crick Institute, London NW1 1AT, UK., Jung S; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. s.jung@weizmann.ac.il. |